Charts Elixiron Immunotherapeutics (Cayman) Limited

Stocks

End-of-day quote Taipei Exchange 14/08/2026			5-day change	1st Jan Change
115.00 ^TWD	+20.80%		+38.89%	-

06-11	Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results For Enrupatinib In Alzheimer's Disease	CI
04-30	Elixiron Immunotherapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Stock exchange

Taipei Exchange 7871 115.00 NT$ +20.80% 697M NT$

Markets		Price	Change	Volumes
Taipei Exchange	7871	115.00TWD	+20.80%	697M NT$

ProRealTime Chart